Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT03418038

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +27 more
Locations
  • Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin, United States
  • Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States
View Trial Details
Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

NCT04329728

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Medical Center of Hematology/Oncology Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735

Conditions
B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
View Trial Details
Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

NCT07284433

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Evanston, Illinois, United States
  • Brown University Health Providence, Rhode Island, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 13 locations
View Trial Details

Related conditions